
Overview
Status
Active
Registry date
2009-03-06
Share capital
7 705 000,00 PLN
Registered address
43, 72-001 Rosówek, Poland
Website
dgs-diagnostics.comWebsite active
Email
Email address current
Phone
Electronic delivery address
AE:PL-37310-59773-CGREU-31
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 20.77mMedianUSD 252.87kAverageUSD 4.59m
Net profit
This companyUSD 861.43kMedianUSD 8.64kAverageUSD 199.03k
Operating costs
This companyUSD 18.82mMedianUSD 267.10kAverageUSD 4.20m
Assets
This companyUSD 29.91mMedianUSD 228.68kAverageUSD 5.39m
Industry
Bank accounts
Registered as a VAT taxpayer on 2009-12-01. Active
49 2360 0005 0000 0045 5029 0309
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $637.4K$637,363 |
Buildings and premises | $16.3M$16,348,853 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Nov 19, 2013 | Call to creditors |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Karol Stanisław Urbański – Attorney-in-fact (sole)
Paweł Muklewicz – Management Board Member
Soren Nielsen – President of the Management Board
René Schneider – Management Board Member
Manner of representation
Each member of the management board may represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Oticon A/s | 99 | $1,337.12 | 0.0642% |
Others | 154,001 | $2,079,970.29 | 99.9358% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Biovicosp. z o.o. | $32,559,077.90 | biovico.com | ||
| InmedS.A. | $13,860,648.96 | inmed.pl | ||
| Verdentsp. z o.o. | $11,260,945.99 | verdent.pl | ||
| Metrum Cryoflexsp. z o.o. | $10,949,020.49 | metrum.com.pl | ||
| Poldentsp. z o.o. | $9,440,759.21 | poldent.pl | ||
| Corning HtlS.A. | $8,708,960.49 | htl.pl | ||
| Lubelskie Zakłady Farmaceutyczne PolfaS.A. | $7,449,773.98 | polfa.pl | ||
| MargomedS.A. | $6,360,594.28 | margomed.com | ||
| YAVOsp. z o.o. | $6,119,186.19 | yavo.com.pl | ||
| Arxam Techsp. z o.o. | $0.00 | arxamtech.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-08-09 | PKD change (Added: 35.11.Z) | |
| 2023-03-15 | Address change (Zeusa 2, 72-006, Mierzyn → 43, 72-001, Rosówek) | |
| 2021-08-12 | Share capital change (5,000.00 PLN → 7,705,000.00 PLN) | |
| 2021-02-24 | PKD change (Removed: 69.20.Z, 70.22.Z, 71.20.B; Added: 26.60.Z, 32.50.Z, 33.13.Z) | |
| 2016-10-07 | PKD change (Added: 69.20.Z, 70.22.Z, 71.20.B) |
FAQ
The main business activity of DGS Diagnostics focuses on manufacture of medical and dental instruments and supplies.
The company was registered in the Polish National Court Register (KRS) on March 6, 2009.
The headquarters is located at: 43, 72-001 Rosówek.
The share capital of the company is PLN 7,705,000 (approx. $2.1 million).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $20,928,598 in 2024, which is an increase of 1.1% compared to 2023.
Yes, the company recorded a net profit of $586,845 in 2024, meaning the company increased its profit by 85.0%.
The largest operating cost category falls under materials and energy. This category amounted to $16,128,482 in 2024, representing 85% of all operating expenses.
Last updated: 2026-07-15